Search Results - "LAWRENTSCHUK, N."

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics by Eapen, R. S., Nzenza, T. C., Murphy, D. G., Hofman, M. S., Cooperberg, M., Lawrentschuk, N.

“…The heterogeneity of prostate cancer has made imaging modalities of crucial importance in this disease. Accurate diagnosis and staging of the volume and extent…”
Get full text

A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer by Holmes, A., Kelly, B. D., Perera, M., Eapen, R. S., Bolton, D. M., Lawrentschuk, N.

“…Purpose The early diagnosis of prostate cancer and subsequent access to the treatment options helps to achieve optimal cancer outcomes. As the treatment…”
Get full text

Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? by Gardiner, B J, Mahony, A A, Ellis, A G, Lawrentschuk, N, Bolton, D M, Zeglinski, P T, Frauman, A G, Grayson, M L

“…Multidrug-resistant gram-negative bacterial (MDR-GNB) infections of the prostate are an increasing problem worldwide, particularly complicating transrectal…”
Get full text

Navigating systemic therapy for metastatic castration-naïve prostate cancer by Kwan, E. M., Thangasamy, I. A., Teh, J., Alghazo, O., Sathianathen, N. J., Lawrentschuk, N., Azad, A. A.

“…Introduction The last decade has seen a remarkable shift in the treatment landscape of advanced prostate cancer, none more so than in the management of…”
Get full text

Robotic multivisceral pelvic resection: experience from an exenteration unit by Smith, N., Murphy, D. G., Lawrentschuk, N., McCormick, J., Heriot, A., Warrier, S., Lynch, A. C.

“…Background Pelvic exenteration remains a viable and effective treatment option for the management of locally advanced or recurrent pelvic malignancy. The aim…”
Get full text

Miniaturised percutaneous nephrolithotomy versus flexible ureteropyeloscopy: a systematic review and meta-analysis comparing clinical efficacy and safety profile by Davis, N. F., Quinlan, M. R., Poyet, C., Lawrentschuk, N., Bolton, D. M., Webb, D., Jack, G. S.

“…Purpose This study aims to comparatively evaluate clinical outcomes of mini-PCNL and FURS for treating urinary tract calculi in a single session. Methods A…”
Get full text

An exploration of testicular cancer survivors’ experience of ejaculatory dysfunction following retroperitoneal lymph node dissection—a sub-study of the PREPARE clinical trial by Conduit, C., Hutchinson, A. D., Leonard, M., O.’Haire, S., Moody, M., Thomas, B., Sim, I., Hong, W., Ahmad, G., Lawrentschuk, N., Lewin, J., Tran, B., Dhillon, H. M.

“…PURPOSEEjaculatory dysfunction secondary to retrograde ejaculation or anejaculation is a complication of retroperitoneal lymph node dissection (RPLND) for…”
Get full text

Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy by Christidis, Daniel, Clarebrough, E., Ly, V., Perera, M., Woo, H., Lawrentschuk, N., Bolton, D.

“…Purpose Prostatic artery embolization (PAE) has seen a recent increase in interest as a treatment for men with benign prostatic obstruction (BPO). The appeal…”
Get full text

Single-use flexible ureteropyeloscopy: a systematic review by Davis, N. F., Quinlan, M. R., Browne, C., Bhatt, N. R., Manecksha, R. P., D’Arcy, F. T., Lawrentschuk, N., Bolton, D. M.

“…Purpose Data assessing the effectiveness of single-use flexible ureteropyeloscopy (FURS) are limited. This study evaluates and compares single-use FURS with…”
Get full text

Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles by Toner, L, Papa, N, Aliyu, S H, Dev, H, Lawrentschuk, N, Al-Hayek, Samih

“…Recent publications suggest the distribution of Candida species causing candiduria may vary geographically, which has implications for the continued efficacy…”
Get full text

Delivery of intracavernosal therapies using needle-free injection devices by O'Kane, D, Gibson, L, du Plessis, J, Davidson, A, Bolton, D, Lawrentschuk, N

“…ED affects a significant proportion of males worldwide. With an ever-aging population the prevalence of ED is predicted to double in the next decade. Oral…”
Get full text

Medical therapy versus transurethral resection of the prostate (TURP) for the treatment of symptomatic benign prostatic enlargement (BPE): a cost minimisation analysis by Davis, Niall F., Jack, G. S., Witjes, W. P., Bjartell, A., Caris, C., Patel, A., de la Taille, A., Lawrentschuk, N., Bolton, D. M., Tubaro, A.

“…Purpose A cost minimisation analysis compares the costs of different interventions’ to ascertain the least expensive over time. We compared different prostate…”
Get full text

Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI) by Wilson, C., Moseshvili, E., Tacey, M., Quin, I., Lawrentschuk, N., Bolton, D., Joon, D.L., Chao, M., Dunshea, T., Kron, T., Foroudi, F.

“…To assess the intrafraction motion of the urinary bladder and delineate the appropriate margin size for radiotherapy planning, for both the full and empty…”
Get full text

Fully robotic retroperitoneal lymph node dissection – a fusion of technologies – a video vignette by Das, A., Coles‐Black, J., Pham, T., Rajkomar, A. K. S., Lawrentschuk, N., Chuen, J., Warrier, S.

Get full text

Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy by Anton, A., Ballok, Z., Bowden, P., Costello, T., Harewood, L., Corcoran, N., Dundee, P., Peters, J., Lawrentschuk, N., Troy, A., Webb, D., Chan, Y., See, A., Siva, S., Murphy, D., Hofman, M.S., Tran, B.

Get full text

Patient derived organoid model of penile squamous cell carcinoma by Teh, J., Guerra, G., Heriot, A., Ramsay, R., Lawrentschuk, N.

Get full text

Image guidance for focal therapy of prostate cancer by Lindner, U., Lawrentschuk, N., Trachtenberg, J.

“…Focal therapy is an appealing strategy for any tumor and in time may prove to be a valuable treatment option for low-risk, carefully selected prostate cancer…”
Get full text

Salvage radical prostatectomy following primary high intensity focused ultrasound for treatment of prostate cancer by Lawrentschuk, N, Finelli, A, Van der Kwast, T H, Ryan, P, Bolton, D M, Fleshner, N E, Trachtenberg, J, Klotz, L, Robinette, M, Woo, H

“…High intensity focused ultrasound for the treatment of primary prostate cancer is increasing in a subset of men seeking definitive treatment with reduced…”
Get more information

Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma by Day, D., Kanjanapan, Y., Kwan, E., Yip, D., Lawrentschuk, N., Davis, I. D., Azad, A. A., Wong, S., Rosenthal, M., Gibbs, P., Tran, B.

“…Background The role of cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) in the era of targeted therapies is currently undefined. In…”
Get full text

Health information quality on the internet in gynecological oncology: a multilingual evaluation by Lawrentschuk, N, Abouassaly, R, Hewitt, E, Mulcahy, A, Bolton, D M, Jobling, T

“…Oncological internet information quality is considered variable, but no comprehensive analysis of gynecological malig- nancies exists. The present authors'…”
Get more information